AlenCiken

Recovery and Survival of All Patients with Narsoplimab

NASDAQ:OMER   Omeros Corporation
Recovery and Survival of All Patients in Study Evaluating Narsoplimab for Treatment of COVID-19-Associated Acute Respiratory Distress Syndrome

-- All six patients, requiring mechanical ventilation prior to treatment, recovered, survived and were discharged from the hospital

-- Narsoplimab treatment was associated with rapid and sustained improvement across all assessed markers of endothelial/cellular damage and/or inflammation

-- Omeros is in discussions with U.S. government agencies regarding acceleration of narsoplimab manufacturing for use in COVID-19 patients

Omeros Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

finance.yahoo.c...-113000978.html?guce_refer...

finance.yahoo.c...-201200741.html?guce_refer...

Haftungsausschluss

Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.